Cancer
Malignant Bladder Neoplasm
CI-CAN-00005866Explore in graph →
Top-level346 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005866Explore in graph →
Clinical trials
1,510 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study(INSPIRE) | unknown | — | 5,350 | Singlera Genomics Inc.INDUSTRY | 1 | Feb 21, 2025 | clinicaltrials |
| NCT05337189 | A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China | unknown | — | 482 | Creative Biosciences (Guangzhou) Co., Ltd.INDUSTRY | 1 | Feb 13, 2025 |
| clinicaltrials |
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | unknown | Phase 1 | 48 | Carisma Therapeutics IncINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT03108196 | Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder | unknown | N/A | 96 | Zhujiang HospitalOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT06565923 | Study on the Staging and Prognosis Model of Bladder Cancer(2024-SR-386) | unknown | — | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06215976 | The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer | unknown | Phase 4 | 78 | Cairo UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT06550947 | ALDOA Expression in Bladder Urothelial Carcinoma | unknown | — | 50 | Assiut UniversityOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06551233 | Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC) | unknown | Phase 1 | 30 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06541821 | Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients | unknown | — | 30 | Selcuk UniversityOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT05822934 | Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer | unknown | Phase 3 | 20 | Assiut UniversityOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT03362801 | SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly(SAMPHYR) | unknown | N/A | 69 | University Hospital, CaenOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT06427993 | Urine DNA Methylation Detection for Hematuria Evaluation | unknown | — | 71 | Changhai HospitalOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT06427291 | Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients | unknown | Phase 1 | 20 | Fudan UniversityOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT06416319 | Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct)(PreAct) | unknown | N/A | 164 | Universitätsmedizin MannheimOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06374914 | Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients | unknown | — | 120 | Dokuz Eylul UniversityOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT05204199 | Role of Microbiome in BCG Responsiveness Prediction(SILENTEMPIRE) | unknown | — | 120 | Cédric PoyetOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 71 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06334406 | Antitumor T Cell Responses in Patients With Bladder Cancer(immunoBLAD) | unknown | — | 33 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Mar 28, 2024 | clinicaltrials |
| NCT06324058 | Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC | unknown | N/A | 190 | Huashan HospitalOTHER | 0 | Mar 21, 2024 | clinicaltrials |
| NCT03549715 | NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma(NEMIO) | unknown | Phase 1 / Phase 2 | 121 | Association Pour La Recherche des Thérapeutiques Innovantes en CancérologieOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT06294054 | Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy(SELECT) | unknown | — | 707 | University Hospital, RouenOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT05710159 | The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients(iBLAD-app) | unknown | — | 100 | Odense University HospitalOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT06032910 | Surgical Mesh in Radical Cystectomy to Prevent Parastomal Hernias | unknown | N/A | 25 | Charles University, Czech RepublicOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04492293 | An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer | unknown | Phase 2 | 115 | Beijing InnoCare Pharma Tech Co., Ltd.INDUSTRY | 1 | Feb 26, 2024 | clinicaltrials |
| NCT04567719 | Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer | unknown | — | 9 | University of Kansas Medical CenterOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05297552 | A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer | unknown | Phase 2 | 40 | RemeGen Co., Ltd.INDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06253091 | Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy | unknown | N/A | 50 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT05829057 | The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 | unknown | Phase 1 | 10 | Zhejiang UniversityOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT04149691 | Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies | unknown | Phase 1 | 42 | Celon Pharma SAINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06245759 | The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients | unknown | — | 120,000 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05193656 | Bladder Cancer Detection Using Convolutional Neural Networks(BLAInostic) | unknown | — | 5,000 | Zealand University HospitalOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT06152666 | Day-case Endourology; Enablers, Barriers, Unexpected Outcomes | unknown | — | 15 | Royal Devon and Exeter NHS Foundation TrustOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06152679 | Day-case Endourology; Patient Experience | unknown | — | 15 | Royal Devon and Exeter NHS Foundation TrustOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06153849 | Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease Followup | unknown | — | 100 | Changhai HospitalOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06115434 | Comparing Operative, Postoperative and Quality of Life of Patients After Salvage and Radical Cystectomy | unknown | — | 80 | Assiut UniversityOTHER | 1 | Nov 3, 2023 | clinicaltrials |
| NCT04155359 | Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients | unknown | — | 444 | miR Scientific LLCINDUSTRY | 1 | Oct 25, 2023 | clinicaltrials |
| NCT05259319 | Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)(IMMUNOs-SBRT) | unknown | Phase 1 | 92 | Centre Georges Francois LeclercOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT05176145 | Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test(DMIA) | unknown | N/A | 400 | VitadxOTHER | 3 | Oct 13, 2023 | clinicaltrials |
| NCT06074484 | A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer | unknown | Phase 2 | 36 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT05220189 | PENK Methylation Test for Detecting Bladder Cancer | unknown | — | 1,549 | Asan Medical CenterOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT05975151 | Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer | unknown | Phase 2 | 63 | Qilu Hospital of Shandong UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06046469 | Validity of Computed Tomography Versus Magnetic Resonance Imaging in Predicting Muscular Invasion of Bladder Cancer | unknown | N/A | 55 | Menoufia UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06034015 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers | unknown | Phase 1 | 48 | Jiangsu Yahong Meditech Co., Ltd aka AsierisINDUSTRY | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06009848 | Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer | unknown | Phase 2 | 20 | Tianjin Medical University Second HospitalOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT06005116 | [68Ga] NOTA-SGC8 in the Staging of Bladder Cancer | unknown | N/A | 64 | RenJi HospitalOTHER | 1 | Aug 22, 2023 | clinicaltrials |
| NCT05824299 | Influence of Anesthesia Methods on CTCs in TURBT Patients | unknown | N/A | 162 | RenJi HospitalOTHER | 1 | Aug 9, 2023 | clinicaltrials |
| NCT05462392 | Robot-assisted Urological Surgeries Using the MicroHand S Robot | unknown | N/A | 136 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Aug 2, 2023 | clinicaltrials |
| NCT05739812 | The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery | unknown | N/A | 100 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT02948543 | Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer(BCG+MM) | unknown | Phase 3 | 501 | University of SydneyOTHER | 2 | Jun 18, 2023 | clinicaltrials |
| NCT05885204 | RARC vs LRC in A Multicenter Cohort Study | unknown | — | 3,815 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jun 1, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Feb 21, 2025source: clinicaltrials